Health Trials

Neoplasms, Germ Cell and Embryonal

2

Review clinical trials related to Neoplasms, Germ Cell and Embryonal. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

HSV G207 in Children With Recurrent or Refractory Cerebellar Brain Tumors

This study is a clinical trial to determine the safety of inoculating G207 (an experimental virus therapy) into a recurrent or refractory cerebellar brain tumor. The safety of combining G207 with a single low dose of radiation, designed to enhance virus replication, tumor cell killing, and an anti-tumor immune response, will also be tested. Funding Source- FDA OOPD

Participants needed: 24
Trial details
Phase: Phase 1Age: 3-21Biological sex: AllType: InterventionalSponsor: M.D. Anderson Cancer CenterUpdated: May 15, 2026Locations: 3
Eligibility criteria

Age ≥ 36 months and < 22 years [+12]

Any treatment outside the allowable guidelines outlined in section 5.1. [+10]

Read more
Status: Recruiting

Spanish Series of Patients Treated With the Radionuclide Lutetium177

This study aims to pool the clinical experience of Spanish centers treating patients with 177Lu-DOTATATE to evaluate the efficacy, tolerance, and safety of the drug in routine clinical practice and to learn about the profiles of patients and tumors treated and the results in each type of patient and tumor.

Participants needed: 5,000
Trial details
Age: 18-100Biological sex: AllType: ObservationalSponsor: Sociedad Española de Medicina Nuclear e Imagen MolecularUpdated: Dec 23, 2022Locations: 20
Eligibility criteria

Written informed consent must be obtained prior to any data collection. [+2]

None

Read more